Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma

Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma
复制标题

DOI:
10.1158/1078-0432.ccr-07-1950
复制
发表时间:
2008-07-15
影响因子:
11.5
通讯作者:
Sasano, Hironobu
Sasano, Hironobu
中科院分区:
医学1区
文献类型:
--
作者:
Niikawa, Hiromichi;Suzuki, Takashi;Sasano, Hironobu

文献摘要

被引文献

相似文献

目的:在人类非小细胞肺癌(NSCLC)中可能存在性别依赖性因素,但其确切作用仍不清楚。因此,我们检测了NSCLC肿瘤内雌二醇浓度,以研究雌激素在NSCLC中的局部作用。实验设计:59例NSCLC冷冻标本可用于液相色谱/电喷雾串联质谱法研究瘤内雌二醇浓度。此外,稳定表达雌激素受体(ER)α的A549 NSCLC细胞(A549 + ER α)或ER β(A549 + ER)用于体外研究。在59例NSCLC患者中,43例(73%)癌组织中雌二醇浓度高于相应的非肿瘤肺组织,肿瘤内雌二醇浓度显著高于相应的非肿瘤性肺(P = 0.0002和2.2倍)。在ER α或ER β阳性病例中,雌二醇的瘤内浓度与芳香化酶表达、肿瘤大小和Ki-67状态呈正相关。在体外研究中,雌二醇显著增加了A549 + ER α或A549 + ER β的细胞增殖,而选择性ER调节剂他莫昔芬或雷洛昔芬显著抑制了这一增殖。A549 + EF α和A549 + ER β细胞均表达芳香化酶。在这些细胞中的细胞增殖水平显着增加睾酮治疗下,它被抑制,除了芳香化酶抑制剂来曲唑。结论:这些结果表明,雌二醇是本地产生的NSCLC主要由芳香化酶和ER α或ER β阳性NSCLC的生长中起着重要的作用。因此,使用选择性ER调节剂和/或芳香酶抑制剂可能在ER和芳香酶均阳性的NSCLC中具有临床有效性。
Purpose: The possible involvement of gender-dependent factors has been suggested in human non-small cell lung carcinomas (NSCLC), but their precise roles remain largely unclear. Therefore, we examined intratumoral estradiol concentrations in NSCLC to examine local actions of estrogens in NSCLC.Experimental Design: Fifty-nine frozen specimens of NSCLC were available for liquid chromatography/electrospray tandem mass spectrometry to study intratumoral estradiol concentrations, In addition, A549 NSCLC cells stably expressing estrogen receptor (ER) alpha (A549 + ER alpha) or ER beta (A549 + ER) were used in vitro studies.Results: Forty-three (73%) of 59 NSCLC showed higher concentration of estradiol in carcinoma tissues than the corresponding nonneoplastic lung tissues from the same patient, and intratumoral estradiol concentrations were significantly (P = 0.0002 and 2.2-fold) higher than the corresponding nonneoplastic lungs. The intratumoral concentration of estradiol was positively correlated with aromatase expression, tumor size, and Ki-67 status in ER alpha- or ER beta-positive cases. In in vitro studies, estradiol significantly increased cell proliferation of A549 + ER alpha or A549 + ER beta, which was significantly suppressed by selective ER modulators, tamoxifen or raloxifene. Both A549 + EF alpha and A549 + ER beta cells expressed aromatase. The cell proliferation level in these cells was significantly increased under treatment with testosterone, and it was inhibited by addition of the aromatase inhibitor letrozole.Conclusions: These results suggest that estradiol is locally produced in NSCLC mainly by aromatase and plays an important role in the growth of ER alpha- or ER beta-positive NSCLC. Therefore use of selective ER modulators and/or aromatase inhibitors may be clinically effective in NSCLC that are positive for both ER and aromatase.